Moderna’s coronavirus vaccine started to be tested on children

The US biotech company Moderna announced that it has started studies to test the effectiveness of the vaccine developed against the corona virus on children.

In the statement made by Moderna, it was stated that the effectiveness of the vaccine on children was started to be tested, and it was reported that the first doses were given to children under 12 years of age.

As part of the clinical trial called KidCOVE, the Moderna vaccine will be tested on approximately 6,750 children between the ages of 6 months and 11 years in the USA and Canada. In the study, which will be carried out in cooperation with national health institutes, the vaccine trial that started with 11-year-old children will continue with the vaccination of younger children every day, depending on the success of the experiment. In the study, a very small dose of vaccine will be administered first and the effectiveness of the vaccine will be tested by increasing the dose in each test.

Moderna’s Chief Executive Officer (CEO) Stephane Bancel said in a press release, “We are delighted to begin trials of mRNA-1273 in healthy children in the US and Canada. “It will help us evaluate its effectiveness,” he said.


In order to evaluate the effectiveness and immune response of the Covid-19 vaccine developed by Oxford University and AstraZeneca in England, trials were initiated on a total of 300 volunteers between the ages of 6 and 17.

In addition to the Oxford / AstraZeneca vaccine, Pfizer and BioNTech’s Covid-19 vaccine is also administered to children. Johnson & Johnson also announced plans for the vaccine developed against coronavirus to be tested in people between the ages of 12 and 18.

The U.S. Food and Drug Administration (FDA) authorized the use of Moderna’s Covid-19 vaccine in adults in December last year.

Source: UAV